BioMarin to Present at the Thomas Weisel Partners Healthcare ... ( NOVATO Calif. Sept. 2 /- ...)

BioMarin to Present at the Thomas Weisel Partners Healthcare Conference

Date:9/2/2009

NOVATO, Calif., Sept. 2 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Jeffrey H. Cooper, Senior Vice President and Chief Financial Officer of BioMarin, will present a company update at the Thomas Weisel Partners Healthcare Conference in Boston on Thursday, September 10, 2009 at 4:25 p.m. ET.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme(R) (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan(R) (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine news :

1. BioMarin to Present at the Bear Stearns 20th Annual Healthcare Conference
2. BioMarin Provides Grant to NORD to Expand PKU Patient Support Services
3. BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono
4. Fairview Specialty Pharmacy Signs Contract With BioMarin for Distribution of Kuvan(TM)
5. BioMarin to Host Fourth Quarter and Full Year 2007 Financial Results Conference Call and Webcast on Tuesday, February 26 at 5:00 p.m. ET (23:00 CET)
6. BioMarin to Present at the Cowen and Company 28th Annual Healthcare Conference
7. BioMarin to Present at the Lehman Brothers Global Healthcare Conference
8. BioMarin Announces Initiation of Clinical Assessment Program for Morquio A Syndrome
9. BioMarin and La Jolla Pharmaceutical Sign Worldwide (Excluding Asia Pacific) Development and Commercialization Agreement for Riquent
10. BioMarin to Present at the 27th Annual J.P. Morgan Healthcare Conference
11. BioMarin Supports Observance of Rare Disease Day February 28

Post Your Comments:

(Date:12/15/2009)... help, experts say , , TUESDAY, Dec. 15 (HealthDay News) ... how to spot the signs of stroke in relatives ... , Emergency medical treatment within three hours of the ... damage and lead to better recovery. , The Kids ... graders in Texas who were divided into two groups. ...

(Date:12/15/2009)... USB devices, today launches SafeConsole 4.0, the web management software ... designed to provide better usability for employees and more control ... of licensing options. , ... Washington, ... a leading provider of secure USB devices, today launches SafeConsole ...

(Date:12/15/2009)... ANGELES, Dec. 15 Accelify is proud to ... Board of Advisors. David will serve as Director of ... join Accelify,s National Board of Advisors. ,, ... School District,s Board of Education in June 1995. As ... population of over 600,000 stretching from Northeast Los Angeles ...

(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...

(Date:12/15/2009)... by the Technology-based Learning SIG of ASTD,s Atlanta ... eLearning designs. This year nominees, eleven (11) ... The Venza Group entry, a highly engaging modular ... selected as the winner of the "Greater Than ... panel of distinguished judges. While announcing the ...

[0] Boosting Kids' Stroke IQ May Save Lives [0] BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices [0] Accelify Announces the Addition of David Tokofsky to its National Board of Advisors [0] Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis [0] The Venza Group Received Top Honors at the American Society of Training & Development (ASTD) eLearning Excellence Awards Ceremony Held on December 10, 2009

... Meds, Fewer Pharmacists ... - Automated pharmacy technology significantly reduces pharmacy error risk, - Half ... ... practices, DURHAM, N.C., April 10 One-third of America,s 225,million ...

... April 10 Hooper Holmes,(Amex: HH ) today announced ... Officer and that Benjamin A. Currier will continue as,Chairman of ... member of the,Board since May 30, 2007, had been named ... on February 6, 2008., John W. Remshard, who had ...

... state,s elderly, disabled, and ... ... cut hundreds of millions of dollars from Medicaid,programs for the elderly, disabled ... the leaders of Florida,s safety net,hospitals warned today., Besides jeopardizing the ...

... Data presented at this weeks 28th Annual Meeting and ... Lung Transplantation (ISHLT) suggest the potential of a significant ... biopsies and personalize transplant patient care. Non-invasive testing ... offer transplant patients personalized care and medication and may ...

... older, then a research team from the University of Reading ... England may have good news for you. , They have ... reversing age-related deficits in memory, according to a study soon ... and Medicine. The researchers working at the Schools of ...

... Multidisciplinary Pain Care Include ... and Pediatrics, GLENVIEW, Ill., April 10 ... announced the recipients of its,second annual Clinical Centers ... outstanding pain care centers. Six,multidisciplinary pain programs were ...

Other Medicine News:Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 2 Health News:Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds 3 Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 2 Health News:Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman 3 Health News:Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn 2 Health News:Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn 3 Health News:Biomarkers may reduce need for biopsies 2 Health News:Biomarkers may reduce need for biopsies 3 Health News:Getting forgetful? Then blueberries may hold the key 2 Health News:American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards 2 Health News:American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards 3

Prescription For Disaster: One-Third of Consumers Experience Prescription Errors, New Survey Finds Hooper Holmes Names Roy Bubbs President and CEO, Benjamin Currier Continues as Chairman Massive Medicaid Cuts Will Impact All Floridians, Safety Net Hospital Leaders Warn Biomarkers may reduce need for biopsies Getting forgetful? Then blueberries may hold the key American Pain Society Announces Recipients of Clinical Centers of Excellence in Pain Management Awards

(Date:12/15/2009)... -- Rib-X Pharmaceuticals, Inc., a company focused on ... for the treatment of serious multi-drug-resistant infections announced ... agreement with Massachusetts General Hospital (MGH). ... Dr. David Hooper of MGH will evaluate Rib-X,s ... to determine resistance development and to validate the ...

(Date:12/15/2009)... Mass., Dec. 15 Decision Resources, one ... for pharmaceutical and healthcare issues, finds that an ... factor for three-quarters of surveyed European oncologists in ... of Avastin for the treatment of breast cancer. ... Forum report entitled European Trends in Targeted ...

(Date:12/15/2009)... Accumetrics, Inc., developer and marketer of ... diagnostic system for measuring an individual,s response to ... doubling in the number of international and U.S. ... support, and significant capital financing that will take ... the company continued its commitment to creating a ...

Breaking Medicine Technology:Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2 Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3 For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 2 For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe 3 Accumetrics Closes 2009 with Positive Outlook 2 Accumetrics Closes 2009 with Positive Outlook 3 Rice opens Cure for Needy on the Web 10435 1 Rice opens Cure for Needy on the Web 10435 2 Rice opens Cure for Needy on the Web 10435 3 Glucosamine Fails Osteoarthritis Test 59832 1 Glucosamine Fails Osteoarthritis Test 59832 2 Good Food Great Idea 3A Student Led Solution to Hunger Hits 1 000 000 Meal Milestone 59830 1 Good Food Great Idea 3A Student Led Solution to Hunger Hits 1 000 000 Meal Milestone 59830 2 Good Food Great Idea 3A Student Led Solution to Hunger Hits 1 000 000 Meal Milestone 59830 3

[0] Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital [0] For Breast Cancer Treatment, an Agent That Can Achieve an Overall Survival Benefit Would Pose the Greatest Challenge to Avastin's Dominance in Europe [0] Accumetrics Closes 2009 with Positive Outlook

... Dec. 3 Wedgewood Pharmacy has,introduced the ... medications for exchange, at no cost. The,program ... program,the company will exchange unopened, expired compounded ... of more than 6,000,medications, including those prepared ...

... significantly reduced partial onset seizure frequency when, ... with refractory epilepsy., ATLANTA, Dec. 3 ... Phase,III trial demonstrating that its antiepileptic drug ... significantly,reduced partial onset seizure frequency when administered ...

Other Medicine Technology:Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem 2 Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem 3 Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem 4 UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets 2 UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets 3 UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets 4

Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem UCB Announces Positive Phase III Trial Results for Keppra XR(TM) (levetiracetam) Extended-Release Tablets

... High Density, multi-frequency, linear flexible ... on the UST-5536, this "Omni-Plane ... sweeps horizontally as well as ... so that target lesions can ...

Super High Density, multi-frequency, end-fire phased array transducer. Point-and-shoot scanning is the benefit of this transducer....

This is a 3D transducer for endovaginal imaging in OB/GYN....

Medicine Products:

Multi Frequency Omni-Plane Flexible Laparoscopic Transducer Multi Frequency End Fire Laparoscopic Transducer Multi Frequency Endovaginal Convex Transducer ASU-1003 Multi Frequency Endovaginal Convex Transducer ASU-1002

BioMarin to Present at the Thomas Weisel Partners Healthcare ...( NOVATO Calif. Sept. 2 /- ...),Health